Bacterial Infections  >>  RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

8 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
RotaTeq (Live attenuated pentavalent Rotavirus oral vaccine) / Merck (MSD)
NCT00443846 / 2006-005445-11: RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Completed
3
247
NA
RotaTeq®, V260, NeisVac-C®
Merck Sharp & Dohme LLC
Meningitis, Meningococcal, Rotavirus Infections
09/07
10/07
NCT00474526 / 2014-004605-33: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants

Completed
3
4545
US, RoW
Meningococcal ACWY Conjugate Vaccine, Menveo, DTaP-IPV-HBV, Pediarix® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Hepatitis B (Recombinant) and Inactivated Poliovirus Vaccine Combined, Hib, ActHIB® (Haemophilus influenzae type b Conjugate Vaccine), Rotavirus, RotaTeq® Rotavirus Vaccine, Live, Oral, Pentavalent, Pneumococcal 7-valent Conjugate Vaccine, Prevnar®, HAV, Havrix® (Hepatitis A Vaccine, Inactivated), MMR-V, ProQuad™ (Measles, Mumps, Rubella and Varicella vaccine), DTaP, Infanrix® (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed)
Novartis Vaccines
Meningitis, Meningococcal
09/08
11/09
NCT01003431: A Study of the Immunogenicity and Safety of Whole-Cell Pertussis Containing Vaccine Administered Concomitantly With RotaTeq™ (V260) or Rotarix™ (V260-036)(WITHDRAWN)

Withdrawn
3
0
RoW
Rotavirus Vaccine, Live, Oral, Pentavalent, Comparator: Rotarix™ administered concomitantly with Tritanrix™ HepB (DTwP), Comparator: RotaTeq™ administered concomitantly with INFANRIX™ (DTaP)
Merck Sharp & Dohme LLC
Rotavirus Gastroenteritis, Diphtheria, Tetanus, Pertussis
08/10
09/10
V419-006, NCT01340937 / 2011-004108-39: A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™

Completed
3
2808
NA
V419, PENTACEL™, Prevnar 13™, RotaTeq™, Recombivax HB vaccine
Merck Sharp & Dohme LLC, MCM Vaccines B.V.
Bacterial Infections, Virus Diseases
12/12
07/13
V419-007, NCT01341639 / 2010-021490-37: Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months

Completed
3
1250
NA
V419, INFANRIX™ hexa, RotaTeq, Prevenar 13, ProQuad™
MCM Vaccines B.V., Merck Sharp & Dohme LLC
Bacterial Infections, Virus Diseases
03/13
03/13
V419-005, NCT01337167 / 2011-004095-10: Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™

Completed
3
1473
NA
V419, DAPTACEL™, PedvaxHIB™, Prevnar 13™, RotaTeq™, V260, PENTACEL™, Recombivax HB vaccine, ActHIB™
Merck Sharp & Dohme LLC, MCM Vaccines B.V.
Bacterial Infections, Virus Diseases
05/13
05/13
NCT01839188 / 2012-004221-25: Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Completed
3
385
NA
PR5I, V419, Vaxelis®, DTaP-HB-IPV-Hib, Pediacel®, DTaP-IPV-Hib, NeisVac-C®, RotaTeq®, Prevenar 13®, PCV-13
MCM Vaccines B.V., Sanofi Pasteur, a Sanofi Company, Merck Sharp & Dohme LLC
Neisseria Meningitidis, Bacterial Infections, Virus Diseases
03/14
03/14
NCT01839175 / 2012-005547-24: Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination

Completed
3
350
Europe
Hexavalent vaccine, Diphtheria, tetanus, pertussis, hepatitis B,, poliomyelitis and Haemophilus influenzae type b conjugate vaccine (adsorbed)., NeisVac-C, Meningococcal group C polysaccharide conjugate vaccine adsorbed, Prevenar 13, Pneumococcal conjugate vaccine (13-valent, adsorbed), RotaTeq, Human-bovine rotavirus reassortants (live) vaccine, Nimenrix, Meningococcal group A, C, W-135 and Y conjugate vaccine, M-M-RVAXPRO, Measles, mumps and rubella vaccine (live)
Sanofi Pasteur, a Sanofi Company
Neisseria Meningitidis, Bacterial Infections, Virus Diseases
07/14
02/15

Download Options